229 related articles for article (PubMed ID: 24103846)
1. Role of IGF-1 pathway in lung fibroblast activation.
Hung CF; Rohani MG; Lee SS; Chen P; Schnapp LM
Respir Res; 2013 Oct; 14(1):102. PubMed ID: 24103846
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.
Choi JE; Lee SS; Sunde DA; Huizar I; Haugk KL; Thannickal VJ; Vittal R; Plymate SR; Schnapp LM
Am J Respir Crit Care Med; 2009 Feb; 179(3):212-9. PubMed ID: 19011156
[TBL] [Abstract][Full Text] [Related]
4. α-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFβ activation or collagen production across multiple models of organ fibrosis.
Sun KH; Chang Y; Reed NI; Sheppard D
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(9):L824-36. PubMed ID: 26944089
[TBL] [Abstract][Full Text] [Related]
5. Notch3 Deficiency Attenuates Pulmonary Fibrosis and Impedes Lung-Function Decline.
Vera L; Garcia-Olloqui P; Petri E; Viñado AC; Valera PS; Blasco-Iturri Z; Calvo IA; Cenzano I; Ruppert C; Zulueta JJ; Prosper F; Saez B; Pardo-Saganta A
Am J Respir Cell Mol Biol; 2021 Apr; 64(4):465-476. PubMed ID: 33493092
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
7. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
8. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
9. Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.
Huang LS; Jiang P; Feghali-Bostwick C; Reddy SP; Garcia JGN; Natarajan V
Free Radic Biol Med; 2017 Nov; 112():162-173. PubMed ID: 28751023
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
11. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
[TBL] [Abstract][Full Text] [Related]
12. Regulation of myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by adrenomedullin.
Kach J; Sandbo N; Sethakorn N; Williams J; Reed EB; La J; Tian X; Brain SD; Rajendran K; Krishnan R; Sperling AI; Birukov K; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L757-64. PubMed ID: 23585227
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast-specific expression of AC6 enhances beta-adrenergic and prostacyclin signaling and blunts bleomycin-induced pulmonary fibrosis.
Liu X; Li F; Sun SQ; Thangavel M; Kaminsky J; Balazs L; Ostrom RS
Am J Physiol Lung Cell Mol Physiol; 2010 Jun; 298(6):L819-29. PubMed ID: 20348281
[TBL] [Abstract][Full Text] [Related]
14. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
Tumelty KE; Smith BD; Nugent MA; Layne MD
J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
[TBL] [Abstract][Full Text] [Related]
15. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
[TBL] [Abstract][Full Text] [Related]
16. PDGF-Ralpha gene expression predicts proliferation, but PDGF-A suppresses transdifferentiation of neonatal mouse lung myofibroblasts.
Kimani PW; Holmes AJ; Grossmann RE; McGowan SE
Respir Res; 2009 Nov; 10(1):119. PubMed ID: 19939260
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
18. Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis.
Kimura T; Monslow J; Klampatsa A; Leibowitz M; Sun J; Liousia M; Woodruff P; Moon E; Todd L; Puré E; Albelda SM
Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L271-L282. PubMed ID: 31188013
[TBL] [Abstract][Full Text] [Related]
19. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
